Irage Broking Services LLP, M Pallonji and Co., Share India Securities Ltd. and promoter Patronus Tradtech LLP acquired shares of Niva Bupa Health Insurance Co. for Rs 309 crore on Monday.
Irage Broking sold 1.09 crore shares for Rs 83.51 apiece, while the same firm mopped up 32 lakh shares for Rs 83.04 apiece. Patronus Tradtech LLP offloaded 1.01 crore shares for Rs 83.91 apiece, and bought 4.3 lakh shares for Rs 82.99 apiece.
-
Indian Markets Turning Corner After Two Tough Years, Says Sandeep Tandon -
NDTV Profit Ignite 2026: Experts See Opportunity In Equities, Stay Bullish For Long-Term -
Buy Right, Sit Tight Does Not Work for Individual Stocks, Says Dinshaw Irani -
'Worst Is Behind': Quant MF Sees Market Bottom, Flags 'Extreme Euphoria' In Midcaps -
India's Mutual Fund Industry Could Become A $1 Trillion Opportunity, Say Fund Managers -
'Foreign Investors Are Baraatis': Raamdeo Agrawal's Take On LTCG Tax -
Stay Invested Through Market Cycles: Raamdeo Agrawal at NDTV Profit Ignite -
Ramesh Damani Remains Bullish On India For Next 20-30 Years, Sees Bargains Amid Market Weakness -
CAS Came After A Long Consultation Process: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFIT IGNITE -
Aim To Cut FPI Onboarding Time From Mth To Five Days: SEBI Chairman Tuhin Kanta Pandey AT NDTV PROFI
Share India Securities purchased 47.4 lakh shares for Rs 83,05 while selling 1.11 crore shares for Rs 82.91 apiece. M Pallonji bought up 1.36 crore shares or 0.74% at Rs 83.95 apiece.
Also Read | Layoffs Are Rising In Tech, But These Skills Are Helping People Unlock Better Pay
Patronus Tech LLP, under the name Fettle Tone LLP, held 17.47% stake in the company as a promoter as of March 2025.
Details regarding the prior ownership stake of the other firms who undertook purchases could not be ascertained.
Shares of Niva Bupa Health Insurance closed 9.9% lower at Rs 83.11 apiece on the NSE, compared to a 0.14% fall in the benchmark Nifty. The stock has risen 12.31% in the last 12 months and fallen 1.19% on a year-to-date basis.
Out of five analysts tracking the company, four have a 'buy' rating on the stock, one recommends 'hold' , according to Bloomberg data. The average of 12-month analysts' price target implies a potential upside/downside of 5.4%.
Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.
